HighTower Advisors’s Avanos Medical AVNS Stock Holding History

HighTower Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,983	Closed	-$264K	–	2415
2019 Q2	$264K	Buy	5,983 +428	+8%	+$18.3K	﹤0.01%	1873
2019 Q1	$245K	Buy	5,555 +640	+13%	+$28.7K	﹤0.01%	1834
2018 Q4	$224K	Sell	4,915 -400	-8%	-$21K	﹤0.01%	1768
2018 Q3	$367K	Buy	+5,315	New	+$342K	﹤0.01%	1619
2018 Q1	–	Sell	-4,579	Closed	-$217K	–	2192
2017 Q4	$217K	Sell	4,579 -233	-5%	-$10.7K	﹤0.01%	1870
2017 Q3	$227K	Buy	+4,812	New	+$205K	﹤0.01%	1827
2016 Q3	–	Sell	-15,080	Closed	-$481K	–	1877
2016 Q2	$481K	Sell	15,080 -917	-6%	-$28.1K	0.01%	1143
2016 Q1	$446K	Sell	15,997 -1,181	-7%	-$31.5K	﹤0.01%	1425
2015 Q4	$570K	Sell	17,178 -478	-3%	-$14.9K	0.01%	1253
2015 Q3	$492K	Buy	17,656 +1,570	+10%	+$54.8K	0.01%	1207
2015 Q2	$651K	Sell	16,086 -6,379	-28%	-$286K	0.01%	930
2015 Q1	$1.11M	Sell	22,465 -8,338	-27%	-$386K	0.02%	767
2014 Q4	$1.4M	Buy	+30,803	New	+$1.21M	0.02%	691

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HighTower Advisors's AVNS Position: Q3 2019 in Review

HighTower Advisors sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 5,983 shares — an estimated $264K sold.

HighTower Advisors first reported a position in AVNS in Q4 2014 and held it in 13 quarters. The position peaked at $1.4M in Q4 2014. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

HighTower Advisors reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
HighTower Advisors sold 5,983 Avanos Medical shares in Q3 2019, an estimated $264K.
HighTower Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 13 quarters.
HighTower Advisors's Avanos Medical position peaked at $1.4M in Q4 2014.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on HighTower Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.